Financing translation: Analysis of the NCATS rare-diseases portfolio

The portfolio of the National Center for Advancing Translational Sciences (NCATS) rare-diseases therapeutic development program comprises 28 research projects initiated at the preclinical stage. Historical data reveal substantially lower costs and higher success rates but longer preclinical timeline...

Full description

Bibliographic Details
Main Authors: Fagnan, David E. (Contributor), Yang, N. Nora (Author), McKew, John C. (Author), Lo, Andrew W. (Contributor)
Other Authors: Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory (Contributor), Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science (Contributor), Massachusetts Institute of Technology. Operations Research Center (Contributor), Sloan School of Management (Contributor)
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS), 2015-10-26T16:46:38Z.
Subjects:
Online Access:Get fulltext